Hanson Wade have taken the decision to cancel this meeting.
Please do accept our apologies for any inconvenience or disappointment this will cause.
Please register your interest here if you would like updates on the meeting or topic.
Welcome to the PI3K Pathways Digital Summit
With 4 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.
The PI3K Pathways Digital Summit is the industry’s only meeting dedicated to overcoming the challenges in developing clinically effective next generation PI3K inhibitors.
Join the online discussion at the only digital platform dedicated to bringing together the community of PI3K experts from large pharma, innovative biotech and research institutes for a unique opportunity to address the challenges of the PI3K and AKT pathway, gain clarity on the mTOR signalling pathway and participate in cross-disciplinary discussions with fellow industry peers.
Bespoke Virtual Platform - How Does It Work?
World-Class Speaker Faculty
Chief Executive Officer & Managing Director
Head of Laboratory Immuno Oncology & Senior Director & Global Strategy Lead
Director Clinical Research Oncology/ Hematology
Chief Scientific Officer